Trexquant Investment LP Heron Therapeutics, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.3 - $6.29 $118,898 - $325,161	-51,695 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.63 - $9.94 $9,764 - $20,963	-2,109 Reduced 3.92%	51,695 $296,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $130,677 - $197,190	15,650 Added 41.02%	53,804 $491,000
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $141,060 - $208,875	13,925 Added 57.47%	38,154 $408,000
Q2 2021 Aug 12, 2021	SELL	$13.27 - $18.48 $55,256 - $76,950	-4,164 Reduced 14.67%	24,229 $376,000
Q1 2021 May 13, 2021	BUY	$14.49 - $20.72 $411,414 - $588,302	28,393 New	28,393 $460,000
Q4 2020 Feb 11, 2021	SELL	$14.61 - $22.14 $1.06 Million - $1.6 Million	-72,449 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$13.67 - $17.77 $606,455 - $788,348	44,364 Added 157.96%	72,449 $1.07 Million
Q2 2020 Aug 07, 2020	SELL	$10.89 - $21.47 $561,335 - $1.11 Million	-51,546 Reduced 64.73%	28,085 $413,000
Q1 2020 May 08, 2020	BUY	$10.23 - $24.56 $327,155 - $785,428	31,980 Added 67.11%	79,631 $935,000
Q4 2019 Feb 12, 2020	BUY	$17.42 - $26.61 $830,080 - $1.27 Million	47,651 New	47,651 $1.12 Million
Q2 2019 Aug 09, 2019	SELL	$16.93 - $26.22 $1.2 Million - $1.85 Million	-70,639 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$23.15 - $28.34 $1.64 Million - $2 Million	70,639 New	70,639 $1.73 Million
Q4 2018 Feb 13, 2019	SELL	$22.03 - $32.01 $471,618 - $685,270	-21,408 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$30.0 - $40.85 $121,440 - $165,360	-4,048 Reduced 15.9%	21,408 $678,000
Q2 2018 Aug 07, 2018	BUY	$26.4 - $42.0 $672,038 - $1.07 Million	25,456 New	25,456 $989,000
Q1 2018 May 03, 2018	SELL	$18.43 - $28.8 $956,646 - $1.49 Million	-51,907 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$14.8 - $18.85 $579,138 - $737,619	39,131 Added 306.29%	51,907 $940,000
Q3 2017 Nov 09, 2017	BUY	$14.65 - $16.85 $187,168 - $215,275	12,776	12,776 $206,000

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$42.7 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$14.2 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$14 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$13.3 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$11.2 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $190M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account